Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure

This publication has 20 references indexed in Scilit:

• MDL 17,043 therapy in severe congestive heart failure: Characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response
  Journal of the American College of Cardiology, 1985
• Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure
  American Heart Journal, 1984
• Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure
  The American Journal of Cardiology, 1984
• Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease
  Clinical Cardiology, 1984
• The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
  Circulation, 1983
• Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.
  Circulation, 1981
• Tolerance to dobutamine after a 72 hour continuous infusion
  The American Journal of Medicine, 1980
• The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
  Circulation, 1977
• Renal arterial pressure, renin secretion, and blood pressure control in trained dogs
  American Journal of Physiology-Legacy Content, 1973
• Metabolism of antidiuretic hormones
  The American Journal of Medicine, 1967